sulfomucin

02/01/1998 - "Sulfomucin-type tumors were predominantly found in the right side colon and followed a relatively favorable course. "
03/01/1993 - "The presence in the mucous membrane around the tumor of moderate or small amounts of sulfomucins as well as a complete absence of sulfo- and cyalomucins in the tumor cells are indices of a favourable prognosis. "
01/01/1992 - "The positive rate of CEA in cancers secreting sulfomucin was higher than that in cancers without sulfomucin. "
11/01/1989 - "The ileal mucosa adjacent to the neoplasm had morphologic features of large-bowel mucosa and was richly populated by sulfomucin-containing goblet cells, which are characteristic of large-bowel mucosa. "
03/01/1985 - "GCM of the adjacent mucosa of the neoplasms showed a decrease in sulfomucin in 95 cases and a marked increase in the labile class III con A reactivity in 97 cases, while the histochemical properties of SCM in this region remained unchanged."

05/01/1985 - "This faecal sulphatase activity may be involved in the degradation of colonic mucus and merits further study but these findings do not explain the relative depletion of colonic mucosal sulphomucins in ulcerative colitis."
05/01/2008 - "Sulphomucin expression is increased in the mucous gel layer of the ulcerative colitis pouch compared with that of the familial adenomatous polyposis pouch. "
05/01/1985 - "Histochemical studies have shown a relative depletion of colonic sulphated mucins (sulphomucins) in active ulcerative colitis. "
05/01/2008 - "Sulphomucin expression in ileal pouches: emerging differences between ulcerative colitis and familial adenomatous polyposis pouches."
05/01/2008 - "We characterized the expression of sialomucin and sulphomucin in pouches fashioned for familial adenomatous polyposis and ulcerative colitis. "

10/01/2019 - "A4gnt/Chst4 DKO mice lack gastric sulfomucins but developed gastric adenocarcinoma. "
06/01/2005 - "Moreover, there were foci of adenosis adjacent to the adenocarcinoma foci, which also did not contain sulfomucin. "
11/01/1989 - "Sulfomucin-containing goblet cells were also found in the inflammatory lesions biopsied from the ileal stomas of both patients, as well as from the adenocarcinoma found in one patient. "
04/01/1989 - "IM secreting sulphomucins was seen to be associated with gastric adenocarcinoma."
10/01/1988 - "Adenocarcinomas had a sulphomucin or mixed secretion pattern with transitional features in the adjacent mucosa mucosa (18/27). "

01/01/1996 - "No significant change was demonstrated in the mean sulfomucin staining score comparing normal and colon cancer patients. "
04/01/1995 - "We studied mucin production in the unsectioned colon, demonstrating that ACFs producing sulphomucins (like the normal distal rat colon) were progressively reduced when ACF multiplicity increased, whereas ACFs containing sialomucins (correlated with an increased risk of colon cancer) or both sulphomucins and sialomucins increased with crypt multiplicity. "
01/01/1996 - "To establish patterns of mucin staining in the colon, a differential staining method was developed separating acid mucins into sialomucins and sulfomucins, and their distribution was studied along the colon of 9 normal subjects, 6 patients with ulcerative colitis in remission and 9 with colon cancer. "

04/01/1990 - "The purpose of this study has been to determine the prevalence of intestinal metaplasia (IM) and its subtypes in normal, benign and malignant states, with special reference to the significance of presence as well as location of sulphomucins in the metaplastic epithelium. "
06/01/1984 - "In a previous study of CELO an incompletely differentiated variant of intestinal metaplasia secreting sulphomucins (type II B) was found. "
05/01/2008 - "Histological specimens were examined according to the updated Sydney system and the ones with incomplete intestinal metaplasia were further stained for sulphomucin visualisation to divide these into types II and III. The overall prevalence of intestinal metaplasia was 19%. "
01/01/2004 - "The area covered by incomplete type of intestinal metaplasia and the proportion of sulfomucins were significantly higher in the esophagus than in the stomach. "
12/01/1999 - "In contrast, sulphomucin expression in NGCC from the same anatomic area is a less sensitive (sensitivity 62%), but more specific (specificity = 90%) marker for the presence of metaplastic epithelium, of either the GC or the multilayered epithelial cell type and thus may represent an early or incomplete form of intestinal metaplasia."